Article
12 Sep 2025
解读人类遗传资源管理最新问答：人源细胞系、肿瘤异种移植模型（CDX/PDX）、CAR-T治疗材料监管问题
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in China
AUTHORS CONTENT
Article
12 Sep 2025
生命科学行业License-in/out合同争议要点分析（三）：不竞争条款
Article
12 Sep 2025
医药临床研究风险高悬下的合规提示与应对建议
Article
12 Sep 2025
观点 | 生命科学行业License-in/out合同争议要点分析（四）：首付款是否可能退回？
Article
11 Sep 2025
创新药交易新视角：评析药品试验数据保护制度新草案（中英双语）
Article
29 Aug 2025
Six Key Insights Into China Biotech's NewCo Model
Article
04 Apr 2025
揭秘中国创新药企NewCo模式实战中的"六脉神剑"
Article
02 Dec 2022
Overview Of China Drug Review Annual Report (2015-2021)
Article
25 Nov 2022
人遗相关法规之《科学技术部行政处罚实施办法（征求意见稿）》重点快评
Article
22 Nov 2022
Highlights On The New HGR-Related Administrative Penalty Rule
Article
18 Nov 2022
《药品网络销售监督管理办法》要点解读
Article
18 Nov 2022
Measures For Supervision And Administration Of Online Sales Of Drugs: Analysis Of Key Aspects And Impacts
Article
10 Nov 2022
新法速评 — 2022年《药品召回管理办法》要点解读
Article
10 Nov 2022
Highlights On The New Drug Recall Regulation Of 2022
Article
25 May 2022
Highlights On New Draft Rules Of Drug Administration
Article
24 Apr 2022
《人类遗传资源管理条例实施细则（征求意见稿）》亮点快评
Article
12 Apr 2022
Highlights On The Draft HGR Regulations Implementing Rules
